PT Ikapharmindo Putramas
bd_4feabcb21afdf385 · schema v1 · pii pii-v1
Full breach record for PT Ikapharmindo Putramas →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group Coinbasecartel on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
PT Ikapharmindo Putramas is a pharmaceutical company located in Jakarta, Indonesia. Founded in 1979, the company is committed to improving public health by providing quality medicines & healthcare products. The company runs under Kalbe Farma Group and manufactures various products including prescription drugs, over-the-counter medications, and health supplements.
J jump to incidentP pin to compareR raw source
Incident timeline — mostly unverified
? — ?
Breach window unknown
Feb 16, 2026
Claim posted
—
No filing yet · watching
Compliance clocks stay unassessable until a regulatory filing lands. Dashed segments fill in automatically when corroboration arrives.
Claim → filing
—
Compliance clock
Not assessable
Evidence ladder
Attacker assertion only. Establishes: claim date, group, alleged victim.
Unlocks: incident narrative, operational impact. Still no compliance clock.
Unlocks: discovery date, data types, affected count, compliance clock.
Unlocks: materiality, stated response, full audit trail. Ceiling removed.
No regulatory filing corroborates this yet — it is the attacker's own assertion. Watch this entity to be notified the moment a filing corroborates or contradicts it.
Source ceiling
- actor name
- victim claim
- ransom/leak status
- discovery date
- materiality
- notification
- affected count
- confirmed data types
- compliance clock
The ✕ fields stay blank until a regulatory filing or victim disclosure lands.
coinbasecartel
According to ransomware.live, CoinbaseCartel specializes in data acquisition through system access and strategic partnerships. It focus exclusively on data exfiltration—our operations never involve system encryption or operational disruption.